Shyam Patel is an Oncology physician affiliated with University of Massachusetts Chan Medical School. OpenAlex indexes 136 publications with 1,648 citations (h-index 18).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
55 Lake Ave N
Worcester, MA 016550002
Telephone
774-442-3903Provider last certified this registry record 7 May 2025.
Industry payments
15 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Syndax Pharmaceuticals, Inc.Program year20257 payments
- TAIHO ONCOLOGY, INC.Program year20252 payments
- Rigel Pharmaceuticals, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
34.6%Nucleoside Metabolic Inhibitor12.9%Inqovi100%Part D≥16 patientsKinase inhibitor12.9%Jakafi100%Part D<11 patients+ 2 more classes in this area
Anti-infectives
27.4%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor11.9%Valacyclovir100%Part D≥17 patientsFluoroquinolone Antibacterial9.8%Levofloxacin100%Part D≥14 patients+ 1 more class in this area
Nervous system
12.3%Opioid Agonist6.5%Oxycodone Hcl66%Tramadol Hcl34%Part D<11 patientsBenzodiazepine5.7%Lorazepam100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Choosing Between HLA-Mismatched Unrelated and Haploidentical Donors: Donor Age Considerations
Biology of Blood and Marrow Transplantation
2025 - Contemporary management paradigms and emerging therapeutics for myelodysplastic syndromes/neoplasms
British Journal of Haematology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Fernando Martinez, MD
University of Massachusetts Chan Medical School
Richard Irwin, MD
University of Massachusetts Chan Medical School
Kimberly Yonkers, MD
University of Massachusetts Chan Medical School
Craig Lilly, MD
University of Massachusetts Chan Medical School
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”